Skip to main content
In stock | Cellular Therapy

Allogeneic Regulatory T-Cell Immunotherapy (HSPC + T cells)

Oncology Type Hematologic
Drug Class / Mechanism Engineered allogeneic cell therapy — HSPC, regulatory T cells, conventional T cells
No Image
Description

Allogeneic Regulatory T-Cell Immunotherapy (HSPC + T cells) is classified as an Engineered allogeneic cell therapy — HSPC, regulatory T cells, conventional T cells, sourced for use within our Cellular Therapy portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic Category Cellular Therapy
Oncology Type Hematologic

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3